Working to facilitate rapid translation of scientific discoveries into therapeutics

Graeme Kay

Graeme Kay cutted-2

Graeme Kay, PhD, MRSC, MAPS, SRPharmS

Dr Kay is a senior lecturer and programme leader for Instrumental Analytical Sciences at Robert Gordon University, Aberdeen, UK. He joined the University in January 2005 after a brief spell in industry as a development chemist. Previous to that he was employed at Edinburgh Napier University as a researcher in organo-medicinal chemistry. He was educated at Edinburgh Napier University where he gained a BSc (Hons) degree in Applied Chemistry and a PhD in Anti-Cancer Medicinal Chemistry. Dr Kay’s research interests include: (i) the design and synthesis of novel prodrugs for the treatment of nephropathic cystinosis, (ii) the formulation of cysteamine in various dosage forms, (iii) the design and synthesis of amino-substituted anthraquinones as potential anti-cancer agents and (iv) the use of peptide substrates to enable the site-specific delivery of bio-imaging agents.

2013-2021©European Society for Translational Medicine (EUSTM)